IOmx Therapeutics
Description: iOmx develops first-in-class cancer therapeutics targeting immune checkpoint modulators to break tumor immune resistance & reactivate host immunity.
Country: Germany
Based in: Munich
Founded: 2016
Funding Stage: Series A/B
Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.
